UNICA IRIS Institutional Research Information System

FLORIS, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 90.792
NA - Nord America 3.563
AS - Asia 1.580
SA - Sud America 257
AF - Africa 32
OC - Oceania 4
Totale 96.228
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 90.026
US - Stati Uniti d'America 3.500
SG - Singapore 643
CN - Cina 548
BR - Brasile 208
SE - Svezia 205
DE - Germania 149
VN - Vietnam 140
UA - Ucraina 90
GB - Regno Unito 72
FI - Finlandia 69
FR - Francia 46
CA - Canada 40
JP - Giappone 35
HK - Hong Kong 33
IN - India 33
KR - Corea 30
NL - Olanda 30
ES - Italia 28
AR - Argentina 22
BD - Bangladesh 20
IQ - Iraq 16
PL - Polonia 16
IR - Iran 14
MX - Messico 13
AT - Austria 11
ZA - Sudafrica 10
ID - Indonesia 9
CZ - Repubblica Ceca 8
IE - Irlanda 8
IL - Israele 8
MA - Marocco 7
RU - Federazione Russa 7
BE - Belgio 6
CO - Colombia 6
EG - Egitto 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
CL - Cile 5
EC - Ecuador 5
LT - Lituania 5
PK - Pakistan 5
TR - Turchia 5
AU - Australia 4
GR - Grecia 4
BH - Bahrain 3
ET - Etiopia 3
PS - Palestinian Territory 3
PY - Paraguay 3
UY - Uruguay 3
DK - Danimarca 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
OM - Oman 2
PA - Panama 2
PH - Filippine 2
SA - Arabia Saudita 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BJ - Benin 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GT - Guatemala 1
GY - Guiana 1
IS - Islanda 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TH - Thailandia 1
TW - Taiwan 1
Totale 96.228
Salva come PNG Salva come JPEG
Città #
Cagliari 87.327
Uta 2.433
Dallas 538
Ashburn 386
Singapore 287
Fairfield 286
Boardman 191
Woodbridge 177
Houston 168
Chandler 154
Beijing 129
Wilmington 120
Nyköping 116
Ann Arbor 112
Cambridge 107
Seattle 97
Los Angeles 88
Shanghai 86
Santa Clara 61
Dong Ket 58
Dearborn 52
Munich 51
Hefei 49
Boston 44
Helsinki 43
Buffalo 41
Jacksonville 41
The Dalles 40
New York 37
Chicago 31
Hong Kong 31
Rome 29
Seoul 29
Ho Chi Minh City 28
Milan 24
Redwood City 24
Nanjing 21
São Paulo 20
Guangzhou 19
Tokyo 19
Toronto 19
San Diego 18
Phoenix 16
Hanoi 15
London 15
Amsterdam 14
Warsaw 14
Nuremberg 13
Orem 13
Brooklyn 12
Montreal 12
Redondo Beach 12
Denver 11
Nanchang 11
Baghdad 10
Lauterbourg 10
Madrid 10
Turku 10
Elk Grove Village 9
Hebei 9
Salt Lake City 9
Frankfurt am Main 8
Mountain View 8
Stockholm 8
Belo Horizonte 7
Changsha 7
Düsseldorf 7
Hyderabad 7
Johannesburg 7
Lappeenranta 7
Rio de Janeiro 7
Brussels 6
Buenos Aires 6
Dhaka 6
Dublin 6
Falls Church 6
Poplar 6
Portsmouth 6
San Mateo 6
Tashkent 6
Vienna 6
Washington 6
Atlanta 5
Baku 5
Brno 5
Kiryat Ono 5
Mumbai 5
Paris 5
Sassari 5
Sestu 5
Tehran 5
Wuhan 5
Xi'an 5
Anguillara 4
Casablanca 4
Charlotte 4
Chennai 4
City of London 4
Columbus 4
Council Bluffs 4
Totale 94.078
Salva come PNG Salva come JPEG
Nome #
FRI0357 DRUG-INDUCED REMISSION AND SUBCLINICAL ACTIVITY IN PSORIATIC ARTHRITIS: TRANSCRIPTIONAL PROFILING TO CHARACTERIZE THE DISEASE STATE 10.715
Assessment Of Circulating Endothelial Cells And Their Progenitors As Potential Biomarkers Of Disease Activity And Damage Accrual In Behçet's Syndrome 3.132
Expression analysis of HLA-E and NKG2A and NKG2C receptors points at a role for natural killer function in ankylosing spondylitis 3.029
Gene expression profiling of monozygotic twins affected by psoriatic arthritis 3.006
Physician's global assessment in psoriatic arthritis: A multicenter GRAPPA study 2.989
Musculoskeletal manifestations as determinants of quality of life impairment in patients with systemic lupus erythematosus 2.878
Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001–2012 2.794
AIF-1 gene does not confer susceptibility to Behçet's disease: Analysis of extended haplotypes in Sardinian population 2.778
Population-based analysis of hospitalizations in a West-European region revealed major changes in hospital utilization for patients with systemic lupus erythematosus over the period 2001-2012 2.765
Protective effects of hydroxychloroquine against accelerated atherosclerosis in systemic lupus erythematosus 2.604
Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series 2.575
Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus 2.309
Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: An alternative to standard of care 2.263
Molecular modifications induced by mud-bath therapy in patients with osteoarthritis 2.225
Polymyalgia rheumatica: an autoinflammatory disorder? 2.218
PET/CT scan revealing active idiopathic inflammatory myopathy with normal serum sarcoplasmic enzymes levels 2.163
Demyelinating syndrome in SLE encompasses different subtypes: Do we need new classification criteria? Pooled results from systematic literature review and monocentric cohort analysis 2.162
Killer-cell immunoglobulin-like receptors (KIR) and HLA-class I heavy chains in ankylosing spondylitis 2.130
Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis) 2.073
Predictors of flares in Systemic Lupus Erythematosus: Preventive therapeutic intervention based on serial anti-dsDNA antibodies assessment. Analysis of a monocentric cohort and literature review 2.049
Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: Systematic literature review and analysis of a monocentric cohort 1.999
Comment on: Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease 1.899
The proposed role of ultrasound in the management of giant cell arteritis in routine clinical practice 1.778
New approaches in tumor necrosis factor antagonism for the treatment of psoriatic arthritis: certolizumab pegol 1.667
Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study 1.598
Development and preliminary validation of the Behçet's syndrome Overall Damage Index (BODI) 1.575
Treatment target in newly diagnosed systemic lupus erythematosus: The association of lupus low disease activity state and remission with lower accrual of early damage 1.515
Accrual of organ damage in Behçet's syndrome: trajectory, associated factors, and impact on patients' quality of life over a 2-year prospective follow-up study 1.418
Use of Physician Global Assessment in systemic lupus erythematosus: a systematic review of its psychometric properties 1.347
The use of ultrasound to assess giant cell arteritis: review of the current evidence and practical guide for the rheumatologist 1.242
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort 1.125
Targeted Therapies in Axial Psoriatic Arthritis 1.119
Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis 1.100
Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network 1.050
Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study 1.036
Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study 1.010
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus 1.005
Effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI study 982
Imbalanced MMP-3 and MMP-12 serum levels in systemic lupus erythematosus patients with Jaccoud's arthropathy and a distinctive MRI pattern 960
Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review 900
Telemedicine in rheumatology: high specificity and sensitivity of follow-up virtual video consultations during COVID-19 pandemic 877
Patterns of Anti-Inflammatory and Immunomodulating Drug Usage and Microvascular Endothelial Function in Rheumatoid Arthritis 856
Efficacy, Safety, and Tolerability of Treatments for Systemic Sclerosis-Related Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis 851
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 822
Organ damage is a major determinant of work productivity impairment in Behçet's Syndrome: a post-hoc analysis of the BODI validation study 810
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 800
Relationship between the prevalence of subclinical tenosynovitis and treatment in patients with RA in clinical remission: STARTER study 795
Discordance between patient and physician global assessment of disease activity in Behçet’s syndrome: a multicenter study cohort 785
Musculoskeletal ultrasound may narrow the gap between patients and physicians in the assessment of rheumatoid arthritis disease activity 765
Oxidative Stress Biomarkers and Peripheral Endothelial Dysfunction in Rheumatoid Arthritis: A Monocentric Cross-Sectional Case-Control Study 734
The Challenging Differentiation of Psoriatic Arthritis from Other Arthropathies and Nonspecific Arthralgias in Patients with Psoriasis: Results of a Cross-Sectional Rheumatologic Assessment of a Large Dermatologic Cohort 710
SAT0035 IS PHARMACOLOGICAL CLINICAL REMISSION SYNONYMOUS WITH BIOLOGICAL INACTIVE DISEASE? DIFFERENTIAL GENE EXPRESSION ANALYSIS IN RHEUMATOID ARTHRITISAND HEALTY CONTROLS 674
Prevalence and clinical significance of electrocardiographic signs of atrial myopathy in rheumatoid arthritis: results from the EDRA study 521
Treatment of psoriasis with different classes of biologics reduces the likelihood of peripheral and axial psoriatic arthritis development 449
Quality of Life in Systemic Lupus Erythematosus and Other Chronic Diseases: Highlighting the Amplified Impact of Depressive Episodes 283
Mood Disorder Questionnaire Positivity in Systemic Lupus Erythematosus and Other Chronic Diseases including Screen Bipolar Disorders or Rhythm and Energy Dysregulation Syndromes (DYMERS) 186
Psychometric Properties of Patient Global Assessment in Psoriatic Arthritis: A Systematic Literature Review 179
Stratifying patients by TNFSF13B genotype revealed increased flare and renal flare risk, but a greater benefit from belimumab: a potential biomarker for personalized treatment in systemic lupus erythematosus 136
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort 44
The role of Anti-PAD4, Anti-CarP, and Anti-RA33 antibodies combined with RF and ACPA in predicting abatacept response in rheumatoid arthritis 41
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry 25
Influence of gender on Behçet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçet's Disease Registry 24
Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet's syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial 15
Effectiveness of ixekizumab over 24 months in different clinical scenarios in psoriatic arthritis: results from the Gruppo Italiano Studio Early Arthritis multicentric prospective registry 8
null 5
Totale 96.577
Salva come PNG Salva come JPEG
Categoria #
all - tutte 120.954
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.954
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216.182 0 0 0 0 0 1.668 1.073 819 449 828 836 509
2021/20225.007 425 243 264 187 355 302 254 297 520 600 908 652
2022/20236.923 568 895 696 503 508 763 403 565 515 548 621 338
2023/202413.146 362 372 389 777 1.052 1.409 1.457 4.113 495 567 1.210 943
2024/202531.521 11.169 8.598 5.106 2.186 1.164 1.147 1.259 86 199 163 221 223
2025/20262.521 335 403 623 347 478 335 0 0 0 0 0 0
Totale 96.577